PET/CT Imaging in COVID-19 Patients

18F-αvβ6-binding-peptide PET/CT in Patients Post SARS CoV2 Infection

This is a PET/CT study using the 18F-αvβ6-binding-peptide.The goal of this study is to evaluate this peptide in patients after infection with SARS CoV2.

The goal of the study is to to acquire 18F-αvβ6-BP PET/CT images in patients diagnosed with SARS CoV2 and to demonstrate the ability of 18F-αvβ6-BP to detect lung damage.

Inclusion Criteria:

• Men and women age ≥ 18 yrs
• Diagnosed with SARS CoV2
• Must have 2 sequential COVID negative tests prior to each scan
• Must have no previous lung disease prior to SARS CoV2 infection
• Lung image (Xray or CT) taken during infectious/ diagnosis period
• Will sign the IRB-approved consent form
• Able to remain motionless for up to 30-60 minutes per scan.

Exclusion Criteria:

• Life expectancy <3 mo
• Women who are pregnant or breast-feeding
• Patients who cannot undergo PET/CT scanning because of weight limits(>350lbs)
• Lack of availability for follow-up assessments
• Re-infection with SARS CoV2 between scan sessions
• Other active infectious respiratory illness